HIMS May 2024 17.000 call
| Previous close | 0.0300 |
| Open | 0.0300 |
| Bid | 0.0000 |
| Ask | 0.0500 |
| Strike | 17.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.0300 - 0.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.25k |
- Yahoo Finance Video
Investors await Nvidia earnings, commodities on the rise: Morning Brief
On today's episode of The Morning Brief, Yahoo Finance Hosts Seana Smith and Brad Smith break down some of the market's (^DJI, ^IXIC, ^GSPC) biggest stories and give an overview of the trading week ahead. The stock market opened mixed on Monday, with the Dow Jones Industrial Average opening below its recent record high of 40,000. Morgan Stanley's Michael Wilson, previously bearish on S&P 500 growth, is now bullish on the index's potential, revising his target from 4,500 to 5,400. Meanwhile, metal commodities continue to surge after gold (GC=F) and silver futures (SI=F) reached fresh highs last week. BofA Global Research Head of Metals Research Michael Widmer explains that precious metals are in a "buy-the-dip market." Nvidia (NVDA) is set to post its first quarter earnings for the fiscal 2025 year on Wednesday. Moor Insights & Strategy Founder and CEO Patrick Moorhead believes the chip company will outperform expectations, citing increasing demand as the artificial intelligence race heats up. AI is increasingly becoming a trend, as the number of times AI has been mentioned on earnings calls this quarter has notably risen compared to last quarter, according to Goldman Sachs Investment Research. Veteran market strategist and founder of RandyFrederickMedia.com Randy Frederick adds that "AI is going to change things as much as the Internet did when it came about 30, 40 years ago." All eyes are on Paramount (PARA, PARAA) as Sony (SONY) and Apollo Global (APO) have reportedly signed non-disclosure agreements in their latest efforts to court the media giant. On the healthcare front, Hims & Hers Health (HIMS) stock has jumped on the announcement that the telehealth provider will introduce compounding injectable GLP-1 weight-loss drugs to its services. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Melanie Riehl
- Yahoo Finance Video
Weight loss: Hims & Hers introduce access to GLP-1 injections
Hims & Hers Health (HIMS) stock has jumped up upon the telehealth provider introducing compounding injectable GLP-1 weight-loss drugs to its services. The Morning Brief's Seana Smith and Brad Smith report on Hims & Hers' latest offering in the weigh-loss drug category. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.
Business WireHims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
SAN FRANCISCO, May 20, 2024--Hims & Hers Health, Inc., the leading health and wellness platform, today announced the addition of GLP-1 injections to its comprehensive weight loss portfolio, giving customers an affordable way to consistently access safe, high-quality weight loss treatment.
